The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Texas MPN Workshop 2020 | Inflammation as a predisposing factor to MPN development
Angela Fleischman
• 19 Aug 2020
Angela Fleischman, MD, UCI Health, Orange County, CA, discusses the role of inflammation as a predisposing factor to acquiring myeloproliferative neoplasms (MPN), as well as its role in diagnosis, prognosis and disease monitoring. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
